These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 15318544)

  • 21. [Use of low molecular weight heparin in women with recurrent pregnancy loss].
    Todorova K; Ivanov S
    Akush Ginekol (Sofiia); 2004; 43 Suppl 4():31-6. PubMed ID: 15673011
    [No Abstract]   [Full Text] [Related]  

  • 22. Low molecular weight heparins: practical considerations.
    Kessler CM
    Semin Hematol; 1997 Oct; 34(4 Suppl 4):35-42. PubMed ID: 9399408
    [No Abstract]   [Full Text] [Related]  

  • 23. Use of low-molecular-weight heparin from the first trimester of pregnancy: a retrospective study of 111 consecutive pregnancies.
    Deruelle P; Denervaud M; Hachulla E; Ducloy-Bouthors AS; Valat AS; Puech F; Trillot N; Hatron PY; Subtil D
    Eur J Obstet Gynecol Reprod Biol; 2006 Jul; 127(1):73-8. PubMed ID: 16242833
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ProCGlobal and endogenous thrombin potential during pregnancy.
    Hron G; Kyrle PA; Kaider A; Philipp K; Pabinger I; Kollars M; Eichinger S
    Am J Obstet Gynecol; 2010 Nov; 203(5):463.e1-6. PubMed ID: 20598285
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of low molecular weight heparin in pregnancy.
    Melissari E; Parker CJ; Wilson NV; Monte G; Kanthou C; Pemberton KD; Nicolaides KH; Barrett JJ; Kakkar VV
    Thromb Haemost; 1992 Dec; 68(6):652-6. PubMed ID: 1337628
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 'Heparin rebound' means the opposite in cardiac surgery (bleeding) and in cardiology (thrombosis).
    Koracevic G
    Blood Coagul Fibrinolysis; 2010 Mar; 21(2):198-9. PubMed ID: 20118712
    [No Abstract]   [Full Text] [Related]  

  • 27. [Preventing adverse obstetric outcome in women with thrombophilia].
    Verspyck E
    Ann Med Interne (Paris); 2003; 154(5-6):366-9. PubMed ID: 15027592
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Antithrombotic prophylaxis and treatment in thrombophilic disorders in gynaecology and obstetrics].
    Dulícek P; Penka M; Binder T; Unzeitig V
    Vnitr Lek; 2006 Mar; 52 Suppl 1():58-62. PubMed ID: 16637451
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of unfractionated heparin and long-term treatment with low-molecular-weight heparin, bemiparin, on potassium levels.
    Rocha E; Gómez-Outes A; Martínez González J; Kakkar VV
    Thromb Haemost; 2005 Nov; 94(5):1109-10. PubMed ID: 16363259
    [No Abstract]   [Full Text] [Related]  

  • 30. Antithrombotic therapy and pregnancy: consensus report and recommendations for prevention and treatment of venous thromboembolism and adverse pregnancy outcomes.
    Duhl AJ; Paidas MJ; Ural SH; Branch W; Casele H; Cox-Gill J; Hamersley SL; Hyers TM; Katz V; Kuhlmann R; Nutescu EA; Thorp JA; Zehnder JL;
    Am J Obstet Gynecol; 2007 Nov; 197(5):457.e1-21. PubMed ID: 17980177
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Coagulopathy and obstetric anesthesia.
    Benhamou D
    Acta Anaesthesiol Belg; 2003; 54(2):151-5. PubMed ID: 12872432
    [No Abstract]   [Full Text] [Related]  

  • 32. Successful pregnancy outcome in women with bad obstetric history and recurrent fetal loss due to thrombophilia: effect of unfractionated heparin and low-molecular weight heparin.
    Ghosh K; Shetty S; Vora S; Salvi V
    Clin Appl Thromb Hemost; 2008 Apr; 14(2):174-9. PubMed ID: 18160603
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anticoagulant therapy of thromboembolic disease during pregnancy.
    Wehrmacher WH; Karlman RL; Scanlon P; Messmore HL
    Compr Ther; 1998; 24(6-7):289-94. PubMed ID: 9669092
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The use of unfractionated heparin and low molecular weight heparins in pregnancy.
    Casele HL
    Clin Obstet Gynecol; 2006 Dec; 49(4):895-905. PubMed ID: 17082684
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New strategies in anti-thrombotic therapy offer efficacy, cost savings.
    Clin Resour Manag; 2001 Oct; 2(10):155-8, 145. PubMed ID: 11682931
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Use of low-molecular-weight heparins in patients with prosthetic heart valves].
    Hering D; Horstkotte D
    Dtsch Med Wochenschr; 2003 May; 128(20):1129-33. PubMed ID: 12748904
    [No Abstract]   [Full Text] [Related]  

  • 37. Oral anticoagulants and fetal loss.
    Pajor A; Sas G
    Lancet; 1996 Dec 21-28; 348(9043):1734-5. PubMed ID: 8973447
    [No Abstract]   [Full Text] [Related]  

  • 38. Low molecular mass heparin (LMMH) for management of thromboembolic disease in pregnancy.
    van Rooijen M; Bryngelsson AL; Bremme K
    Acta Obstet Gynecol Scand; 2005 Oct; 84(10):1018-9. PubMed ID: 16167922
    [No Abstract]   [Full Text] [Related]  

  • 39. Effects of low-molecular-weight and unfractionated heparin on trophoblast function.
    Quenby S; Mountfield S; Cartwright JE; Whitley GS; Vince G
    Obstet Gynecol; 2004 Aug; 104(2):354-61. PubMed ID: 15292011
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Skin reactions due to low molecular weight heparin in pregnancy: a strategic dilemma.
    Verdonkschot AE; Vasmel WL; Middeldorp S; van der Schoot JT
    Arch Gynecol Obstet; 2005 Feb; 271(2):163-5. PubMed ID: 15112083
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.